As for CVB3, it has been found that KRAS mutation results in compromised IFN-I production in response to viral infection in human lung epithelial cells, contributing to the permissiveness of KRAS-mutant lung adenocarcinoma cells to CVB3 infection [24]. This evidence concerns the gene KRAS and lung adenocarcinoma.